Postpartum Sexual Function in Pregnant Women With COVID-19
Evaluation of Pregnant Women Diagnosed With COVID-19 Using Carol Postpartum Sexual Function and Dyspareunia Scale
1 other identifier
observational
140
1 country
1
Brief Summary
The aim of this study is to identify women with postpartum sexual dysfunction and dyspareunia risk in the early period and to use the treatment and care services they need effectively. Our secondary aim is to reveal the difference in sexual life in the postpartum period between healthy pregnant women and pregnant women diagnosed with COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2020
CompletedStudy Start
First participant enrolled
May 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedMarch 30, 2023
March 1, 2023
4 months
May 14, 2020
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale
In the study planned to be carried out, it is aimed to identify women at risk of postpartum sexual dysfunction and dyspareunia early and benefit from the treatment and care services they need effectively.
3 months
Secondary Outcomes (1)
Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale
3 Months
Study Arms (2)
COVID-19
Pregnant women with COVID-19 who have given birth
Control
Healthy pregnant women who have given birth
Eligibility Criteria
In the reproductive age between 18-45 years old, two groups of 70 people will be selected, consisting of puerperant diagnosed with COVID-19 and healthy puerperant. Patients who have cesarean or vaginal delivery at the end of the study group, who do not have sexual intercourse dysfunction for another reason (such as Stage 3-4 perineal injury, vaginismus) will be selected.
You may qualify if:
- Pregnant Patient with COVID-19
You may not qualify if:
- Those with known sexual dysfunction disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Halkali, 34307, Turkey (Türkiye)
Related Publications (1)
Lopez-Lapeyrere C, Serna-Gomez N, Hernandez-Lopez AB, Perez-Garcia MF, Tejeda-Esteban A, Solis-Munoz M. The development and validation of a new postpartum sexual function and dyspareunia assessment tool: The Carol Scale. Midwifery. 2018 Mar;58:27-36. doi: 10.1016/j.midw.2017.11.008. Epub 2017 Dec 6.
PMID: 29277039BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist of Obstetrics and Gynecology
Study Record Dates
First Submitted
May 14, 2020
First Posted
May 15, 2020
Study Start
May 14, 2020
Primary Completion
September 25, 2020
Study Completion
September 30, 2020
Last Updated
March 30, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share